Treatment of proximal deep vein thrombosis with a novel synthetic compound (SR90107A/ORG31540) with pure anti-factor Xa activity - A phase II evaluation

H R Buller*, R Cariou, A Gallus, M Gent, J Ginsberg, M H Prins, A Lensing, M Levi, N Nurmohammed, J Hirsh, R Roberts, J W ten Cate, H Decousus, P Mismetti, A Buchmuller, [No Value] Charlet, A Viallon, J van der Meer, [No Value] Meinardi, K MeijerF Piovella, M Barone, C Beltrametti, S Serafini, R A Kraaijenhagen, M M W Koopman, H H T Jagt, M B R Muller, M V Kooy, S Nauta, A S Gallus, D Coghlan, C Rich, P Prandoni, A Scudeller, L Scarano, A Girolami, R Baker, E Tan, J Cooney, J Eikelboom, J Ninet, C Dolmazon, M H G Madoux, B Coppere, G G Nenci, G Agnelli, F Falcinelli, M Morini, A d'Angelo, Rembrandt Inv

*Corresponding author for this work

    Research output: Contribution to journalArticleAcademicpeer-review

    153 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Treatment of proximal deep vein thrombosis with a novel synthetic compound (SR90107A/ORG31540) with pure anti-factor Xa activity - A phase II evaluation'. Together they form a unique fingerprint.

    Pharmacology, Toxicology and Pharmaceutical Science

    Keyphrases